During the recent session, uniQure N.V. (NASDAQ:QURE)’s traded shares were 1.16 million, with the beta value of the company hitting 1.11. At the last check today, the stock’s price was $17.90, reflecting an intraday gain of 16.28% or $2.51. The 52-week high for the QURE share is $38.80, that puts it down -116.76 from that peak though still a striking 30.06% gain since the share price plummeted to a 52-week low of $12.52. The company’s market capitalization is $688.86M, and the average intraday trading volume over the past 10 days was 0.72 million shares, and the average trade volume was 556.02K shares over the past three months.
uniQure N.V. (QURE) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.70. QURE has a Sell rating from 0 analyst(s) out of 19 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 17 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.96.
uniQure N.V. (NASDAQ:QURE) trade information
uniQure N.V. (QURE) registered a 16.28% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 16.28% in intraday trading to $17.90 this Wednesday, 06/22/22, hitting a weekly high. The stock’s 5-day price performance is 15.02%, and it has moved by 12.17% in 30 days. Based on these gigs, the overall price performance for the year is -49.59%. The short interest in uniQure N.V. (NASDAQ:QURE) is 3.83 million shares and it means that shorts have 7.18 day(s) to cover.
The consensus price target of analysts on Wall Street is $52.35, which implies an increase of 65.81% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $34.00 and $90.00 respectively. As a result, QURE is trading at a discount of -402.79% off the target high and -89.94% off the low.
uniQure N.V. (QURE) estimates and forecasts
Statistics show that uniQure N.V. has underperformed its competitors in share price, compared to the industry in which it operates. uniQure N.V. (QURE) shares have gone down -29.60% during the last six months, with a year-to-date growth rate less than the industry average at -150.28% against 1.00. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -111.30% this quarter and then drop -46.80% in the quarter after that. In the rating firms’ projections, revenue will decrease -86.20% compared to the previous financial year.
Revenue for the current quarter is expected to be $11.83 million as predicted by 15 analyst(s). Meanwhile, a consensus of 15 analyst(s) estimates revenue growth to $2.79 million by the end of Sep 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $190.02 million and $1.99 million respectively. In this case, analysts expect current quarter sales to shrink by -93.80% and then jump by 40.30% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 34.50%. While earnings are projected to return 350.30% in 2022.
uniQure N.V. is due to release its next quarterly earnings between July 25 and July 29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
uniQure N.V. (NASDAQ:QURE)’s Major holders
uniQure N.V. insiders own 6.41% of total outstanding shares while institutional holders control 91.63%, with the float percentage being 97.90%. Blackrock Inc. is the largest shareholder of the company, while 255 institutions own stock in it. As of Mar 30, 2022, the company held over 4.37 million shares (or 9.36% of all shares), a total value of $78.91 million in shares.
The next largest institutional holding, with 3.79 million shares, is of FMR, LLC’s that is approximately 8.13% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $68.55 million.
Also, the Mutual Funds coming in first place with the largest holdings of uniQure N.V. (QURE) shares are iShares Core S&P Smallcap ETF and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. Data provided on Apr 29, 2022 indicates that iShares Core S&P Smallcap ETF owns about 2.58 million shares. This amounts to just over 5.54 percent of the company’s overall shares, with a $38.59 million market value. The same data shows that the other fund manager holds slightly less at 2.11 million, or about 4.53% of the stock, which is worth about $31.58 million.